Heart Disease Clinical Trials in Pennsylvania

Showing 101-120 of 403 trials

Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction

NCT03533517

This is a non-randomized, prospective, multi-center Early Feasibility Study to evaluate the AccuCinch® Ventricular Restoration System in Patients with Heart Failure and Reduced Ejection Fraction (HFrEF).

Heart FailureCardiomyopathy, Dilated

Ancora Heart, Inc.22 participantsStarted Aug 2018

San Francisco, California, United States • Atlanta, Georgia, United States • Louisville, Kentucky, United States +15 more locations

COMPLETEDNA28 miles

The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study

NCT02806570

This is a multi-center, non-randomized, prospective Early Feasibility Study to evaluate the AccuCinch® Ventricular Restoration System in patients with symptomatic heart failure and concomitant functional mitral regurgitation that have stable symptoms on guideline-directed medical therapy

Heart FailureMitral Valve InsufficiencyCardiomyopathies

Ancora Heart, Inc.35 participantsStarted Aug 2016

Atlanta, Georgia, United States • Louisville, Kentucky, United States • Minneapolis, Minnesota, United States +13 more locations

Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction

The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study

Heart Disease Trials in Other Cities

FUnctional diagnoSIs of corONary Stenosis (FUSION)

Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia

ALIVE Expended Access - Clinical Study

PROACTIVE-HF IDE Trial Heart Failure NYHA Class III

Benefits of Microcor in Ambulatory Decompensated Heart Failure

Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT)

Benefits of µCor in Ambulatory Decompensated Heart Failure

Conduction System Pacing Optimized Therapy

A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease

Efficacy and Safety of MEDI6570 in Patients With a History of Myocardial Infarction

Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting

A Study of Mavacamten in Participants With HFpEF and Elevation of NT-proBNP With or Without Elevation of cTnT

Surveillance and Alert-based Multiparameter Monitoring to Reduce Worsening Heart Failure Events

Effect of Fetal Aortic Valvuloplasty on Outcomes

Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects

Communication During Hospitalization About Resuscitation Trial

A Study to Evaluate the Safety of mRNA-0184 in Participants With Heart Failure

Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function

Other Conditions in Pennsylvania